Literature DB >> 11172676

Histone deacetylase: a target for antiproliferative and antiprotozoal agents.

P T Meinke1, P Liberator.   

Abstract

Histone deacetylase (HDAC) and histone acetyltransferase (HAT) are enzymes that influence transcription by selectively deacetylating or acetylating the eta-amino groups of lysines located near the amino termini of core histone proteins. It is well-established that in transcriptionally active chromatin, histones generally are hyperacetylated and, conversely, hypoacetylated histones are coincident with silenced chromatin. Revived interest in these enzymatic pathways and how they modulate eukaryotic transcription has led to the identification of multiple cofactors whose complex interplay with HDAC affects gene expression. Concurrent with these discoveries, screening of natural product sources yielded new small molecules that were subsequently identified as potent inhibitors of HDAC. While predominantly identified using antiproliferative assays, the biological activity of these new HDAC inhibitors also encompasses significant antiprotozoal, antifungal, phytotoxic and antiviral applications. These newly discovered HDAC inhibitors served as lead structures for the development of improved derivatives including related reagents with considerable potential as tools to further elucidate the mechanism of transcriptional regulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11172676     DOI: 10.2174/0929867013373787

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  9 in total

1.  Histone Deacetylase Inhibitor M344 Inhibits Cell Proliferation and Induces Apoptosis in Human THP-1 Leukemia Cells.

Authors:  Xiaohua Li; Ben D Chen
Journal:  Am J Biomed Sci       Date:  2009-06-09

Review 2.  Natural products synthesis: enabling tools to penetrate Nature's secrets of biogenesis and biomechanism.

Authors:  Robert M Williams
Journal:  J Org Chem       Date:  2011-04-12       Impact factor: 4.354

3.  Preclinical Pharmacokinetics Study of R- and S-Enantiomers of the Histone Deacetylase Inhibitor, AR-42 (NSC 731438), in Rodents.

Authors:  Hao Cheng; Zhiliang Xie; William P Jones; Xiaohui Tracey Wei; Zhongfa Liu; Dasheng Wang; Samuel K Kulp; Jiang Wang; Christopher C Coss; Ching-Shih Chen; Guido Marcucci; Ramiro Garzon; Joseph M Covey; Mitch A Phelps; Kenneth K Chan
Journal:  AAPS J       Date:  2016-03-04       Impact factor: 4.009

4.  Design, synthesis, biological evaluation, and structural characterization of potent histone deacetylase inhibitors based on cyclic alpha/beta-tetrapeptide architectures.

Authors:  Ana Montero; John M Beierle; Christian A Olsen; M Reza Ghadiri
Journal:  J Am Chem Soc       Date:  2009-03-04       Impact factor: 15.419

5.  Probing the bioactive conformation of an archetypal natural product HDAC inhibitor with conformationally homogeneous triazole-modified cyclic tetrapeptides.

Authors:  W Seth Horne; Christian A Olsen; John M Beierle; Ana Montero; M Reza Ghadiri
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

6.  Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia.

Authors:  Guillermo Garcia-Manero; Sarit Assouline; Jorge Cortes; Zeev Estrov; Hagop Kantarjian; Hui Yang; Willie M Newsome; Wilson H Miller; Caroline Rousseau; Ann Kalita; Claire Bonfils; Marja Dubay; Tracy-Ann Patterson; Zuomei Li; Jeffrey M Besterman; Gregory Reid; Eric Laille; Robert E Martell; Mark Minden
Journal:  Blood       Date:  2008-05-21       Impact factor: 22.113

Review 7.  Dual Inhibitors Against Topoisomerases and Histone Deacetylases.

Authors:  Young Ho Seo
Journal:  J Cancer Prev       Date:  2015-06

8.  Synthesis and late stage modifications of Cyl derivatives.

Authors:  Phil Servatius; Uli Kazmaier
Journal:  Beilstein J Org Chem       Date:  2022-02-04       Impact factor: 2.883

9.  Antimalarial activity of ultra-short peptides.

Authors:  Lemuel Pérez-Picaso; Benjamín Velasco-Bejarano; A Berenice Aguilar-Guadarrama; Rocío Argotte-Ramos; María Yolanda Rios
Journal:  Molecules       Date:  2009-12-08       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.